Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(32 sites)

United States

Children's of Alabama, Birmingham, Alabama

Arkansas Children's Hospital, Little Rock, Arkansas

Children's Hospital of Los Angeles, Los Angeles, California

Benioff Children's Hospital - Oakland, Oakland, California

Children's Hospital of Orange County, Orange, California

University of California, Davis, Sacramento, California

Rady Children's Hospital, San Diego, California

Benioff Children's Hospital - Mission Bay, San Francisco, California

Children's Hospital Colorado, Aurora, Colorado

Children's National Medical Center, Washington D.C., District of Columbia

Children's Hospital of Atlanta, Atlanta, Georgia

Riley Children's Hospital, Indianapolis, Indiana

CS Mott Children's Hospital, Ann Arbor, Michigan

Children's Hospital of Michigan, Detroit, Michigan

Children's Hospital of Minnesota, Minneapolis, Minnesota

University of Minnesota, Minneapolis, Minnesota

Mercy Children's Hospital, Kansas City, Missouri

Duke University, Durham, North Carolina

Akron Children's Hospital, Akron, Ohio

Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio

Rainbow Babies and Children's Hospital, Cleveland, Ohio

Nationwide Children's Hospital, Columbus, Ohio

Pennsylvania State University, Hershey, Pennsylvania

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania

Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania

Medical University of South Carolina, Charleston, South Carolina

University of Texas Southwestern, Dallas, Texas

Texas Children's Hospital, Houston, Texas

Children's Hospital of San Antonio, San Antonio, Texas

Primary Children's Hospital, Salt Lake City, Utah

Virginia Commonwealth University, Richmond, Virginia

Medical College of Wisconsin, Milwaukee, Wisconsin